[Boston, MA – June 18, 2012] – A number of Hoosier companies and university representatives are heading to the International Biotechnology Industry Organization (BIO) Convention, being held this week in Boston, MA. Represented through the Indiana Health Industry Forum, the Indiana affiliate of BIO, the group is promoting companies, technologies, talent and the support network that have made Indiana a recognized national leader in the life sciences.
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech. The convention offers key networking and partnering opportunities and provides insights and inspiration on the major trends affecting the industry. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world’s largest biotechnology exhibition. In 2011, The BIO Exhibition featured more than 1,800 exhibitors and covered 180,000 square feet with 61 state and international pavilions.
“We are really looking forward to this year’s show”, said Kristin Jones, president of the Indiana Health Industry Forum. “We have a great group of smaller companies that can really benefit from the exposure of being here as well as using this as a chance to promote some of our best biomedical programs and students. We’ve tried to bring together all of the components that make Indiana such a strong cluster and are working to tell the complete story behind what we have”.
In addition to IHIF, companies and universities exhibiting in the booth include: BioConvergence (Bloomington), Cientive Group (Indianapolis), the Fairbanks Institute (Indianapolis), Indiana BioPharma LLC (Indianapolis), Tymora Analytical (West Lafayette), Phlebotics Inc. (West Lafayette), Purdue University/Discovery Park (West Lafayette), Rose-Hulman Institute of Technology (Terre Haute), Ivy Tech Center for the Life Sciences (Bloomington), the University of Notre Dame’s Advanced Diagnostics and Therapeutics Initiative (Notre Dame), and Carroll County, representing Indiana’s Technology Corridor. Other Indiana companies also exhibiting at the show include: Barnes & Thornburg LLP, Commissioning Agents, Inc., and Cook Pharmica. IHIF’s exhibition at BIO is sponsored by: Duke Energy, Commissioning Agents, Inc., Purdue University, the Indy Partnership, and BioCrossroads.
According to Vijay Thukral, CEO of Cientive Group, Inc., BIO provides a great opportunity to see nationaland international trends in the biotech and provides a great opportunity to create new collaborations and identify new clients. “One can be awed by the latent power of biotechnology through the products on display and through ideas and applications being discussed”, says Thukral. “It will provide an opportunity to understand the emerging landscape and how we as Indiana can power our own local Industry”. Cientive is participating in the IHIF booth and will seek new partners and collaborators in development of mathematical tools to provide assessment of safety, efficacy and quality of medical devices and therapeutics that are at preclinical and clinical stages.
The diverse members of the Indiana Health Industry Forum generate the collective voice of the state’s health and life science industry. The Forum connects key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation. Our mission is to make Indiana the premier location to start and grow a health science business. IHIF is the Indiana affiliate organization for the Biotechnology Industry Organization (BIO). For more information, please visit www.ihif.org.
ABOUT THE BIO INTERNATIONAL CONVENTION
The BIO International Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues and food and agriculture. The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2012 BIO International Convention.